PH22198A - Nasal pharmaceutical compositions containing ergot cyclic peptide alkaloid and xanthine - Google Patents

Nasal pharmaceutical compositions containing ergot cyclic peptide alkaloid and xanthine

Info

Publication number
PH22198A
PH22198A PH28445A PH28445A PH22198A PH 22198 A PH22198 A PH 22198A PH 28445 A PH28445 A PH 28445A PH 28445 A PH28445 A PH 28445A PH 22198 A PH22198 A PH 22198A
Authority
PH
Philippines
Prior art keywords
xanthine
pharmaceutical compositions
compositions containing
cyclic peptide
nasal pharmaceutical
Prior art date
Application number
PH28445A
Other languages
English (en)
Inventor
Kiechel Jean-Rene
Plas Danielle
Aceza-Mispelter Francoise
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH22198A publication Critical patent/PH22198A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH28445A 1982-02-01 1983-01-28 Nasal pharmaceutical compositions containing ergot cyclic peptide alkaloid and xanthine PH22198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (1)

Publication Number Publication Date
PH22198A true PH22198A (en) 1988-06-28

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28445A PH22198A (en) 1982-02-01 1983-01-28 Nasal pharmaceutical compositions containing ergot cyclic peptide alkaloid and xanthine

Country Status (27)

Country Link
JP (1) JPS58134017A (it)
AT (1) AT385656B (it)
AU (1) AU565613B2 (it)
BE (1) BE895750A (it)
CA (1) CA1197783A (it)
CH (1) CH653555A5 (it)
DE (1) DE3302949A1 (it)
DK (1) DK164771C (it)
ES (1) ES519450A0 (it)
FI (1) FI81258C (it)
FR (1) FR2539994B1 (it)
GR (1) GR81320B (it)
HK (1) HK59989A (it)
HU (1) HU191512B (it)
IE (1) IE54532B1 (it)
IL (1) IL67822A (it)
IT (1) IT1197558B (it)
KE (1) KE3888A (it)
LU (1) LU84613A1 (it)
MY (1) MY8700766A (it)
NL (1) NL192325C (it)
NZ (1) NZ203117A (it)
PH (1) PH22198A (it)
PT (1) PT76166B (it)
SE (1) SE454402B (it)
SG (1) SG34389G (it)
ZA (1) ZA83673B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CN111936140A (zh) * 2018-01-05 2020-11-13 英倍尔药业股份有限公司 通过精密鼻装置的双氢麦角胺的鼻内递送

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
IT8347646A0 (it) 1983-02-01
IL67822A (en) 1988-02-29
JPH0253406B2 (it) 1990-11-16
AU565613B2 (en) 1987-09-24
ES8502865A1 (es) 1985-02-01
KE3888A (en) 1989-09-01
IT1197558B (it) 1988-12-06
FR2539994B1 (fr) 1986-10-10
NL192325B (nl) 1997-02-03
DK164771B (da) 1992-08-17
CA1197783A (en) 1985-12-10
FI830245A0 (fi) 1983-01-25
IE830187L (en) 1983-08-01
DE3302949A1 (de) 1983-08-11
BE895750A (fr) 1983-08-01
AU1085083A (en) 1983-08-11
ATA30383A (de) 1987-10-15
SG34389G (en) 1989-09-22
MY8700766A (en) 1987-12-31
SE454402B (sv) 1988-05-02
DK164771C (da) 1992-12-28
PT76166A (en) 1983-02-01
FI81258B (fi) 1990-06-29
NZ203117A (en) 1986-12-05
NL8300325A (nl) 1983-09-01
LU84613A1 (fr) 1983-09-08
JPS58134017A (ja) 1983-08-10
DK38183D0 (da) 1983-01-31
CH653555A5 (de) 1986-01-15
DE3302949C2 (it) 1992-05-21
AT385656B (de) 1988-05-10
NL192325C (nl) 1997-06-04
DK38183A (da) 1983-08-02
SE8300495L (sv) 1983-08-02
FR2539994A1 (fr) 1984-08-03
SE8300495D0 (sv) 1983-01-31
ZA83673B (en) 1984-09-26
GR81320B (it) 1984-12-11
FI81258C (fi) 1990-10-10
IE54532B1 (en) 1989-11-08
PT76166B (en) 1986-02-04
HU191512B (en) 1987-02-27
FI830245L (fi) 1983-08-02
HK59989A (en) 1989-08-04
ES519450A0 (es) 1985-02-01
IL67822A0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
IL53419A (en) Pharmaceutical compositions containing certain ergot peptide alkaloids for nasal administration
IL74384A (en) Crf antagonist peptides and pharmaceutical compositions containing them
IL64847A (en) Immunomodulating phosphorylsubstituted muramylpeptide analogues and pharmaceutical compositions containing them
PT85071A (en) Process for the preparation of derivatives of fused cyclic azepin-2-ones and of pharmaceutical compositions containing the same
GB2109795B (en) Ergot peptide alkaloids, their preparation and pharmaceutical compositions containing them
IL78872A0 (en) Morphinan derivatives and pharmaceutical compositions containing them
IL66113A0 (en) Pharmaceutical formulations containing ergot alkaloids
NZ211858A (en) Heterocyclic-substituted cephalosporins and analogues thereof and pharmaceutical compositions
EP0085488A3 (en) Amino acid derivatives and antihypertensive drugs containing them
IL90639A (en) Neplanocin derivatives and analogs and pharmaceutical compositions containing them
PH23384A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof
PT83305A (en) Process for the preparation of xanthine derivatives and pharmaceutical compositions containing them
PH22198A (en) Nasal pharmaceutical compositions containing ergot cyclic peptide alkaloid and xanthine
HK43087A (en) Stable pharmaceutical solutions of vinca alkaloids
IL70379A0 (en) Spiro-oxazolidones,-thiazolidones and imidazolidones and pharmaceutical compositions containing them
IL69450A0 (en) Ergot alkaloids,their production and pharmaceutical compositions containing them
PH18155A (en) Ergot peptide alkaloid derivatives and pharmaceutical compositions containing them
IL67883A0 (en) Ergot peptide alkaloids and their salts,their production and pharmaceutical compositions containing them
PH19334A (en) Ergot peptide derivatives and pharmaceutical compositions containing them
GB8605632D0 (en) Accumulating particles of tobacco into batches
IL67907A (en) 5-phenoxy methyl-oxazolidin-2-one derivatives and pharmaceutical compositions containing them
AU570658B2 (en) Pharmaceutical compositions of ergot alkaloids and heparin
GB2015338B (en) Pharmaceutical compositions containg ergot alkaloids and heparing
ZA831089B (en) Ergot peptide alkaloids
JPS5661392A (en) Ergot peptide alkaloids* their manufacture and medicinal composition